S61G (p.Ser61Gly) variant of BCL10 (B-cell lymphoma/leukemia 10)

S61G (p.Ser61Gly) in BCL10 (B-cell lymphoma/leukemia 10) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Immunodeficiency 37. The available variant effect predictions contribute to a CATVariant prioritization score of 0.52 / 1. The record also includes population frequency data.

S61G (p.Ser61Gly) variant details